贝塔细胞封装的新兴策略用于1型糖尿病治疗
Mette Steen Toftdal1,2, Lars Groth Grunnet2, Menglin Chen1
1Department of Biological and Chemical Engineering, Aarhus University, Aarhus C, 8000, Denmark.
Advanced healthcare materials
|March 7, 2024
概括
糖尿病的先进β细胞疗法面临着免疫排斥和细胞存活率低下等挑战. 研究人员正在开发微和纳米生物材料设备,以克服这些障碍,提高治疗潜力.
科学领域:
- 生物材料科学 生物材料科学
- 细胞疗法细胞疗法
- 免疫学 免疫学 免疫学
背景情况:
- 糖尿病是一种广泛的慢性疾病,影响全球数百万人.
- 贝塔细胞封装疗法为糖尿病治疗提供了一种有前途的方法.
- 显著的障碍阻碍了封装β细胞的有效性和寿命.
研究的目的:
- 审查新兴的研究策略,以克服用于β细胞治疗的微和纳米生物材料封装设备的挑战.
- 突出解决异体反应,氧化和血管化的进步,以改善细胞生存和治疗潜力.
主要方法:
- 研究免疫调节材料和物理免疫屏蔽,以减轻异物反应.
- 开发释放氧气的生物材料,以增强氧气扩散和细胞活力.
- 探索血管性生长因子和预血管化的材料,以促进血管化和营养供应.
主要成果:
- 目前正在制定策略,以减少免疫排斥并延长封装β细胞的存活时间.
- 新的生物材料和技术正在提高向细胞输送氧气和营养的速度.
- 克服这些挑战的进展对于推进β细胞疗法至关重要.
结论:
- 微和纳米生物材料封装设备对于未来的β细胞疗法至关重要.
- 这些策略的持续改进将增强糖尿病治疗的治疗潜力.
- 解决免疫反应,氧化和血管化是成功封装细胞的关键.
相关概念视频
Insulin: Biosynthesis, Chemistry, and Preparation
375
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
375
Diabetes: Management and Pharmacotherapy
282
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
282
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Glucagon-like Receptor Agonists
321
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
321
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
Insulin Secretory Vesicles
5.0K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.0K


